Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Luigi Meroni

Showing results (41-50 of 276) with videos related to

Pageof 28
Sort By:
Current Rheumatology Reports|May 5, 2017
Does APS Impact Women's Fertility?Cecilia Beatrice Chighizola, Maria Gabriella Raimondo, Pier Luigi Meroni
Current Vascular Pharmacology|January 26, 2012
Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritisCecilia Chighizola, Tommaso Schioppo, Francesca Ingegnoli, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2017
Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic DiseaseLuca Moroni, Carlo Selmi, Claudio Angelini, et al.
Journal of Translational Autoimmunity|November 24, 2021
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndromeKatrien M J Devreese, Stéphane Zuily, Pier Luigi Meroni
Arthritis Research & Therapy|August 29, 2014
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkersPier Luigi Meroni, Cecilia Beatrice Chighizola, Francesca Rovelli, et al.
Autoimmunity Reviews|December 14, 2011
The X chromosome and the sex ratio of autoimmunityCarlo Selmi, Enrico Brunetta, Maria Gabriella Raimondo, et al.
Nature Reviews. Rheumatology|May 11, 2011
Pathogenesis of antiphospholipid syndrome: understanding the antibodiesPier Luigi Meroni, M Orietta Borghi, Elena Raschi, et al.
Therapeutic Advances in Musculoskeletal Disease|August 4, 2012
The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trialsEnnio Giulio Favalli, Francesca Pregnolato, Martina Biggioggero, et al.
Journal of Immunology Research|May 29, 2014
Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesMichael Mahler, Pier-Luigi Meroni, Xavier Bossuyt, et al.
Autoimmunity Reviews|June 2, 2012
Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndromeMichael Mahler, Gary L Norman, Pier Luigi Meroni, et al.
Pageof 28

Showing results (41-50 of 276) with videos related to

Sort By:
Pageof 28
Current Rheumatology Reports|May 5, 2017
Does APS Impact Women's Fertility?Cecilia Beatrice Chighizola, Maria Gabriella Raimondo, Pier Luigi Meroni
Current Vascular Pharmacology|January 26, 2012
Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritisCecilia Chighizola, Tommaso Schioppo, Francesca Ingegnoli, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 1, 2017
Evaluation of Endothelial Function by Flow-Mediated Dilation: a Comprehensive Review in Rheumatic DiseaseLuca Moroni, Carlo Selmi, Claudio Angelini, et al.
Journal of Translational Autoimmunity|November 24, 2021
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndromeKatrien M J Devreese, Stéphane Zuily, Pier Luigi Meroni
Arthritis Research & Therapy|August 29, 2014
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkersPier Luigi Meroni, Cecilia Beatrice Chighizola, Francesca Rovelli, et al.
Autoimmunity Reviews|December 14, 2011
The X chromosome and the sex ratio of autoimmunityCarlo Selmi, Enrico Brunetta, Maria Gabriella Raimondo, et al.
Nature Reviews. Rheumatology|May 11, 2011
Pathogenesis of antiphospholipid syndrome: understanding the antibodiesPier Luigi Meroni, M Orietta Borghi, Elena Raschi, et al.
Therapeutic Advances in Musculoskeletal Disease|August 4, 2012
The role of biologic agents in damage progression in rheumatoid arthritis: indirect comparison of data coming from randomized clinical trialsEnnio Giulio Favalli, Francesca Pregnolato, Martina Biggioggero, et al.
Journal of Immunology Research|May 29, 2014
Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodiesMichael Mahler, Pier-Luigi Meroni, Xavier Bossuyt, et al.
Autoimmunity Reviews|June 2, 2012
Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndromeMichael Mahler, Gary L Norman, Pier Luigi Meroni, et al.
Pageof 28